Abstract: The problem addressed by the present invention is to provide compounds and pharmaceutical compositions that demonstrate strong antibacterial activity against gram-negative bacteria and drug-resistant gram-negative bacteria. Compounds represented by general formula [1] (in the formula, each symbol is as described in the specification.) or salts thereof have strong antibacterial activity against gram-negative bacteria, including Pseudomonas aeruginosa, and drug-resistant gram-negative bacteria, including multidrug-resistant Pseudomonas aeruginosa, and pharmaceutical compositions containing these compounds or salts are useful as antimicrobials.
| # | Name | Date |
|---|---|---|
| 1 | 202047043413-Correspondence_Form-1 And POA_20-12-2021.pdf | 2021-12-20 |
| 1 | 202047043413-FORM-26 [03-11-2020(online)].pdf | 2020-11-03 |
| 2 | 202047043413-FORM 3 [12-03-2021(online)].pdf | 2021-03-12 |
| 2 | 202047043413.pdf | 2021-10-18 |
| 3 | 202047043413-FORM 3 [06-09-2021(online)].pdf | 2021-09-06 |
| 4 | 202047043413-FORM 3 [12-03-2021(online)].pdf | 2021-03-12 |
| 4 | 202047043413.pdf | 2021-10-18 |
| 5 | 202047043413-Correspondence_Form-1 And POA_20-12-2021.pdf | 2021-12-20 |
| 5 | 202047043413-FORM-26 [03-11-2020(online)].pdf | 2020-11-03 |